Monday, March 23, 2020
3M has a unique and critical responsibility in pandemic preparedness and response -- a responsibility I and all our people take very seriously. Our most urgent priority is the safety of our employees, healthcare workers and the public. Since the initial COVID-19 outbreak, we've ramped up to maximum production levels of N95 respirators and doubled our global output to a rate of more than 1.1 billion per year, or nearly 100 million per month. In the United States we are producing 35 million respirators per month; of these, more than 90% are now designated for healthcare workers, with the remaining deployed to other industries also critical in this pandemic, including energy, food and pharmaceutical companies. As a global company, we also manufacture respirators in Europe, Asia and Latin America, and our products are being similarly deployed to support the COVID-19 response in those respective regions.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.